NCT03979222 - Observational Cohort Study of a National Extracorporeal Membrane Oxygenation Service for Adults With Respiratory Failure: the NHS ECMO Study. | Biotech Hunter

Enrollment

1,205

Participants

Timeline

Start Date

December 1, 2011

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions

Acute Respiratory Failure

Interventions

DEVICE

Extracorporeal Membrane Oxygenation

ECMO provides extracorporeal gas exchange through use of a membrane oxygenator. Blood is drained from a central vein and returned after oxygenation into either the venous or arterial circulation dependent on configuration.

All Listed Sponsors

collaborator

Royal Papworth Hospital Clinical Trials Unit

UNKNOWN

collaborator

Aberdeen Royal Infirmary, NHS Grampian

UNKNOWN

collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

collaborator

Royal Brompton & Harefield Hospitals NHS Foundation Trust

UNKNOWN

collaborator

Royal Papworth Hospital NHS Foundation Trust

UNKNOWN

collaborator

University Hospitals of Leicester NHS Foundation Trust

UNKNOWN

collaborator

Manchester University NHS Foundation Trust

OTHER_GOV

collaborator

NHS England

OTHER_GOV

lead

University of Cambridge

OTHER